Magnetic-Driven Hydrogel Robots Loaded with Mitomycin for Active Therapy of Bladder Cancer

Area of Science:

• Biomedical Engineering
• Materials Science
• Oncology

Background:

• Intravesical drug instillation for bladder cancer has limitations including poor drug targeting and gravity-dependent distribution.
• Suboptimal patient experience is a significant drawback of current bladder cancer treatment methods.

Purpose of the Study:

• To develop an innovative bladder cancer treatment using sodium alginate hydrogel magnetic robots as mitomycin drug carriers.
• To improve drug targeting, uniformity, and patient experience in bladder cancer therapy.

Main Methods:

• Fabrication of magnetic-driven hydrogel robots with mitomycin (MHRMs) by mixing alginate, neodymium-iron-boron nanoparticles, and mitomycin.
• Formation of MHRMs in a calcium chloride solution.
• Controlled injection and helical motion of MHRMs within the bladder using a magnetic surgical platform.

Main Results:

• MHRMs uniformly coated the bladder wall with mitomycin via helical motion.
• This method improved therapeutic efficiency and patient experience compared to traditional drug perfusion.
• The MHRMs effectively inhibited tumor cell proliferation.

Conclusions:

• The study presents a novel microrobot-based strategy for targeted and uniform drug delivery in bladder cancer treatment.
• This approach demonstrates significant potential for precision medicine applications in oncology.
• The developed MHRMs offer a promising alternative to conventional intravesical therapies.